Skip to content

OCT Pilot in Esophagus

Advanced Angle-Resolved Low Coherence Interferometry (a/LCI) Systems for Improved Clinical Utility: An Optical Coherence Tomography (OCT) Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03434834
Enrollment
53
Registered
2018-02-15
Start date
2018-09-25
Completion date
2020-03-25
Last updated
2021-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Barrett Esophagus

Brief summary

This is a pilot study to test a newly developed optical coherence tomography (OCT) device to determine 1) whether adequate tissue contact can be attained to acquire high quality images, and 2) to identify if these images can discern whether the imaged tissue is squamous or Barrett's Esophagus (BE) epithelium.

Interventions

DEVICEoptical coherence tomography

OCT measurements of 5 locations in the esophagus

Sponsors

University of North Carolina, Chapel Hill
CollaboratorOTHER
National Cancer Institute (NCI)
CollaboratorNIH
Duke University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Presenting to University of North Carolina (UNC) for routine care upper endoscopy 2. Meet one of the following criteria: 1. Presenting to UNC for upper endoscopy of GI conditions without esophageal symptomology for with no history of gastroesophageal reflux disease (GERD) or other esophageal condition affecting the epithelium (asymptomatic controls), OR, 2. History of dysplastic or non-dysplastic Barrett's Esophagus with prague criteria C1+ or M3+ 3. Aged 18 to 80 4. Able to read, comprehend, and understand the informed consent document.

Exclusion criteria

1. Prior esophageal surgery (uncomplicated nissen fundoplication OK) 2. Pregnant women 3. Unable to provide written informed consent

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Imaged Sites Correctly Categorized as Squamous Mucosaat baselinePercentage of imaged sites correctly categorized by OCT as squamous mucosa when compared to endoscopy.
Percentage of Imaged Sites Correctly Categorized as Barrett's Mucosaat baselinePercentage of images site correctly categorized by OCT as Barrett's mucosa when compared to endoscopy.

Secondary

MeasureTime frameDescription
Percentage of Imaged Sites With Adequate Tissue Contact to Acquire a High Quality Imageat baselinePercentage of imaged sites that achieved adequate tissue contact to acquire high quality OCT images.

Countries

United States

Participant flow

Participants by arm

ArmCount
OCT of Esophagus
All participants who were able to swallow the OCT probe had optical coherence tomography (OCT) imaging of the esophagus, with measurements in at least 5 locations.
53
Total53

Withdrawals & dropouts

PeriodReasonFG000
Overall Studyunable to swallow OCT probe16

Baseline characteristics

CharacteristicOCT of Esophagus
Age, Continuous66.3 years
STANDARD_DEVIATION 11.9
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
53 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
53 Participants
Region of Enrollment
United States
53 Participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
48 Participants
Stage of Barrett's Esophagus
Barrett's Esophagus with high grade dysplasia
21 Participants
Stage of Barrett's Esophagus
Barrett's Esophagus with low grade dysplasia
24 Participants
Stage of Barrett's Esophagus
non-dysplastic Barrett's Esophagus
8 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 53
other
Total, other adverse events
8 / 53
serious
Total, serious adverse events
0 / 53

Outcome results

Primary

Percentage of Imaged Sites Correctly Categorized as Barrett's Mucosa

Percentage of images site correctly categorized by OCT as Barrett's mucosa when compared to endoscopy.

Time frame: at baseline

Population: Participants who completed the study.

ArmMeasureValue (NUMBER)
OCT of EsophagusPercentage of Imaged Sites Correctly Categorized as Barrett's Mucosa84.6 percentage of imaged sites
Primary

Percentage of Imaged Sites Correctly Categorized as Squamous Mucosa

Percentage of imaged sites correctly categorized by OCT as squamous mucosa when compared to endoscopy.

Time frame: at baseline

Population: Participants who completed the study.

ArmMeasureValue (NUMBER)
OCT of EsophagusPercentage of Imaged Sites Correctly Categorized as Squamous Mucosa93.1 percentage of imaged sites
Secondary

Percentage of Imaged Sites With Adequate Tissue Contact to Acquire a High Quality Image

Percentage of imaged sites that achieved adequate tissue contact to acquire high quality OCT images.

Time frame: at baseline

Population: Participants who completed the study.

ArmMeasureValue (NUMBER)
OCT of EsophagusPercentage of Imaged Sites With Adequate Tissue Contact to Acquire a High Quality Image80.5 percentage of imaged sites

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026